Can a Two-Drug combo make arthritis treatment work better?
NCT ID NCT01895764
Summary
This study tested whether adding methotrexate to adalimumab treatment helps prevent the body from developing antibodies against adalimumab in people with ankylosing spondylitis. Researchers enrolled 110 adults with active ankylosing spondylitis who hadn't responded well to standard anti-inflammatory drugs. The main goal was to see if this drug combination could make the treatment more effective by reducing the body's immune response against the medication.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANKYLOSING SPONDYLITIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Médecine polyvalente, CH de SAINT NAZAIRE
Saint-Nazaire, 44606, France
-
Rhumatologie / IPROS, CHR d'ORLEANS
Orléans, 45032, France
-
Rhumatologie, CH de BLOIS
Blois, 41000, France
-
Rhumatologie, CH de SAINT BRIEUC
Saint-Brieuc, 22027, France
-
Rhumatologie, CHD LA ROCHE SUR YON
La Roche-sur-Yon, 85925, France
-
Rhumatologie, CHR du MANS
Le Mans, 72037, France
-
Rhumatologie, CHRU de BREST
Brest, 29609, France
-
Rhumatologie, CHRU de NANTES
Nantes, 44093, France
-
Rhumatologie, CHRU de POITIERS
Poitiers, 86021, France
-
Rhumatologie, CHRU de RENNES
Rennes, 35203, France
-
Rhumatologie, CHRU de TOURS
Tours, 37044, France
Conditions
Explore the condition pages connected to this study.